Compulsory pharmaceutical licensing is little more than government theft
… laws, policies, and practices that fail to provide adequate and effective IP … Should H.R. 6505 become law, patients around the world would pay with …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
patentlaw
The RECAP Project and their main page over at the Free Law Project … One patent describes this process in far more detail than I would actually use …
-
In: PATENT NEWS
The Deity’s Advocate
In court, Deepak, 32, has described the deity as a naishtika brahmacharya, and argued that Ayyappa is entitled to a protection of his individual rights …
-
In: PATENT NEWS
Patent Legal Assistant
View details and apply for this patent assistant job in London with Law Support on totaljobs. A rare opportunity for someone with previous patent …
-
In: PATENT NEWS
Call For Papers: Chanakaya National Law University – One day National Seminar on Intellectual …
Chanakya National Law University is organizing a one day National Seminar on “Intellectual Property Rights: Emerging Issues and Challenges” which …
-
In: PATENT NEWS
Seven Steps to Cohesively Combining In-House Legal Departments in a Merger or Acquisition
Carlo also is Adjunct Professor of Law at University of Houston Law Center and a frequent speaker on IP topics. Previously, he practiced law at several …
-
In: PATENT NEWS
Effect of Brexit on unitary patents
A major concern is regarding Intellectual Property Rights (IPR) and Laws, … Therefore, Brexit won’t have any effect on the EPO’s patent system, and …
-
In: PATENT NEWS
Powering up TZ joint ventures: Key legal issues
Intellectual property (IP) is another important legal consideration. Will the local firm or the foreign investor make IP available to the joint venture?
-
In: PATENT NEWS
Bt4m worth of fake brand-name goods seized in Chon Buri
Surachate said the operation stemmed from the Thailand-US cooperation in cracking down on goods violating the IP law as well as on their …
-
In: PATENT NEWS
PTAB Shoots Down Pfizer’s Bid To Review Avastin Patent
Law360 (August 3, 2018, 7:39 PM EDT) — The Patent Trial and Appeal Board has turned down Pfizer Inc.’s challenge to a patent covering Genentech …